TD Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18K Hold
197
﹤0.01% 740
2025
Q4
$1.41K Hold
197
﹤0.01% 639
2025
Q3
$2.1K Sell
197
-110
-36% -$1.08K ﹤0.01% 577
2025
Q2
$2.98K Buy
307
+57
+23% +$588 ﹤0.01% 540
2025
Q1
$3.72K Buy
250
+5
+2% +$77 ﹤0.01% 416
2024
Q4
$3.66K Buy
245
+4
+2% +$65 ﹤0.01% 383
2024
Q3
$4.61K Buy
241
+3
+1% +$62 ﹤0.01% 350
2024
Q2
$4.92K Buy
238
+4
+2% +$79 ﹤0.01% 318
2024
Q1
$4.41K Buy
234
+3
+1% +$51 ﹤0.01% 339
2023
Q4
$3.33K Sell
231
-60
-21% -$816 ﹤0.01% 346
2023
Q3
$5.06K Buy
291
+4
+1% +$83 ﹤0.01% 326
2023
Q2
$5.98K Buy
287
+4
+1% +$87 ﹤0.01% 319
2023
Q1
$6.66K Buy
283
+3
+1% +$81 ﹤0.01% 300
2022
Q4
$7.81K Buy
280
+3
+1% +$77 ﹤0.01% 263
2022
Q3
$6K Buy
+277
New +$8.36K ﹤0.01% 266
2022
Q1
Sell
-280
Closed -$9K 268
2021
Q4
$9K Buy
280
+3
+1% +$98 ﹤0.01% 275
2021
Q3
$9K Buy
277
+2
+0.7% +$64 ﹤0.01% 258
2021
Q2
$8K Buy
+275
New +$9.05K ﹤0.01% 257

Other funds holding OGN

TD Capital Management's OGN Position: Q1 2026 in Review

TD Capital Management held its Organon & Co (OGN) position steady in Q1 2026 at 197 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

TD Capital Management first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $9K in Q4 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • TD Capital Management held 197 shares of Organon & Co worth $1.18K as of Q1 2026.
  • TD Capital Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #740 holding.
  • TD Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
  • TD Capital Management's Organon & Co position peaked at $9K in Q4 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.